Back to Search
Start Over
Entecavir-induced neutropenia in an adult living donor liver transplant recipient: Successful conversion to tenofovir alafenamide.
- Source :
-
Clinical case reports [Clin Case Rep] 2023 Aug 11; Vol. 11 (8), pp. e7741. Date of Electronic Publication: 2023 Aug 11 (Print Publication: 2023). - Publication Year :
- 2023
-
Abstract
- At 22 weeks post-transplantation for HBV-related cirrhosis, an adult woman developed neutropenia which was aggravated by COVID-19 (ANC 0.4 × 10 <superscript>9</superscript> /L). Covid resolution and all "conventional" modifications were ineffective. Success within 2 weeks was achieved by switching entecavir to tenofovir alafenamide. A step-by-step judicious approach to post-transplant neutropenia is vital.<br /> (© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.)
Details
- Language :
- English
- ISSN :
- 2050-0904
- Volume :
- 11
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Clinical case reports
- Publication Type :
- Report
- Accession number :
- 37575459
- Full Text :
- https://doi.org/10.1002/ccr3.7741